News & Analysis
- Data & Tools
- Login | Register
Contrary to appearances, Latin America’s largest economy is developing a more favourable environment for pharma and biotech innovators.
12 August 2022
A fresh ordinance extends INPI’s 2019 plan to reduce the backlog of pending applications by recognising search or examination results where these are available from foreign patent offices for corresponding applications in the same family.
18 May 2022
The INPI harnessed examination work done abroad as well as cutting-edge technology to reduce pileup of applications by 80%
21 April 2022
Patents covering pharmaceutical and non-pharmaceutical related matter will be subject to two distinct terms of protection, according to the latest publication from INPI. Applicants should check whether any pending cases are affected by this change.
13 April 2022
Keen to build on the success of its PPH programmes, Brazil has signed a memorandum of understanding with France that aims to facilitate technical cooperation in intellectual property.
06 April 2022
Recent developments in tax legislation will improve the process of remitting royalties arising from IP contracts. These include facilitating a smoother registration process and discarding existing limitations to royalty payments abroad
16 February 2022
Brazil has consolidated its effective Patent Prosecution Highway strategy by extending the number of applications that can be submitted to the National Institute of Industrial Property.
19 January 2022
The long-awaited 10-year strategy, which is designed to improve the IP system in Brazil with the civil and governmental support, has finally come into force.
12 January 2022
From President Biden’s backing for a covid IP waiver through a new linkage system in China to big changes in Brazil, it was an action-packed 2021 for the life sciences industries
21 December 2021
Brazil has enjoyed consistent success with PPH programmes, as evidenced by Phase II of the programme starting and finishing considerably earlier than anticipated.
24 November 2021
Get unlimited access to all IAM content